Jaipur
08042782001
+918824471531

Isosorbide Mononitrate IP 30 mg Sustained-Release Tablets for Angina & Heart Health

Isosorbide mononitrate

Cardiovascular health is essential for overall well-being, and conditions like angina pectoris and ischemic heart disease are common concerns worldwide. Angina occurs when the heart muscle does not receive enough oxygen-rich blood, often resulting in chest pain, tightness, or discomfort. Managing these conditions requires medications that improve blood flow to the heart and reduce the heart’s workload.

CARDULES ISMN SR 30, containing Isosorbide Mononitrate IP 30 mg, is a sustained-release nitrate medication widely prescribed for the prevention and management of angina pectoris. Isosorbide Mononitrate works by relaxing and dilating blood vessels, improving oxygen supply to the heart, and reducing cardiac workload.

CARDULES ISMN SR 30 provides consistent, long-lasting protection against angina attacks, helping patients lead an active and comfortable life. With proper medical supervision, it effectively supports heart health and prevents complications associated with reduced blood supply to the heart.

Uses of CARDULES ISMN SR 30

CARDULES ISMN SR 30 is primarily used for preventing chest pain and managing conditions associated with reduced blood flow to the heart.

Common uses include:

  • Prevention of angina pectoris (chest pain due to ischemic heart disease)

  • Management of chronic stable angina

  • Reduction in the frequency and severity of angina attacks

  • Adjunct therapy in ischemic heart disease

  • Improvement of exercise tolerance in patients with angina

  • Prevention of angina triggered by physical exertion or stress

It is important to note that CARDULES ISMN SR 30 is designed for prevention of angina rather than for immediate relief during an acute episode.

Benefits of Isosorbide Mononitrate 30 mg

CARDULES ISMN SR 30offers multiple therapeutic benefits, making it a preferred option for long-term management of angina and heart-related disorders.

1. Prevents Angina Attacks

By dilating blood vessels, Isosorbide Mononitrate improves blood flow to the heart, preventing episodes of chest pain caused by reduced oxygen supply.

2. Sustained-Release Formulation

The SR (Sustained Release) formulation ensures a steady release of the drug over time, providing consistent protection throughout the day.

3. Reduces Cardiac Workload

Relaxation of blood vessels lowers the heart’s workload and reduces oxygen demand, minimizing cardiac stress and potential complications.

4. Improves Exercise Tolerance

Patients taking CARDULES ISMN SR 30 often experience increased stamina and reduced discomfort during physical activity.

5. Enhances Quality of Life

By reducing chest pain and preventing angina attacks, this medication allows patients to carry out daily activities more comfortably.

6. Well-Tolerated

Isosorbide Mononitrate is generally safe when taken as prescribed, with minimal serious side effects when used correctly.

Dosage of CARDULES ISMN SR 30

The dosage of CARDULES ISMN SR 30 should be individualized according to the patient’s condition, response, and other health factors.

General Dosage Guidelines:

  • Typically taken once daily in the morning

  • Take the tablet whole with water, do not crush or chew

  • Can be taken with or without food

Important Instructions:

  • Maintain a consistent dosing schedule for best results

  • Do not abruptly stop the medication without consulting your doctor

  • Dose adjustments may be needed based on blood pressure, heart rate, or side effects

Monitoring:

  • Regular monitoring of blood pressure and heart rate is recommended

  • Inform your doctor about all other medications to avoid interactions, especially with other nitrates or erectile dysfunction drugs

Side Effects of CARDULES ISMN SR 30

CARDULES ISMN SR 30 is generally well-tolerated, but some patients may experience side effects, particularly at the start of therapy.

Common Side Effects:

  • Headache (usually mild to moderate)

  • Dizziness or lightheadedness

  • Flushing or warmth of the face and neck

  • Nausea or mild stomach discomfort

  • Fatigue

Rare or Serious Side Effects:

  • Severe hypotension (low blood pressure)

  • Rapid or irregular heartbeat

  • Severe allergic reactions such as rash, swelling, or difficulty breathing

  • Fainting due to excessive drop in blood pressure

Most side effects are temporary and often resolve as the body adjusts to the medication. Severe or persistent symptoms should be reported to a healthcare professional immediately.

Precautions and Warning

Certain precautions are necessary to ensure the safe and effective use of CARDULES ISMN SR 30.

Precautions:

  • Inform your doctor if you have low blood pressure, heart failure, liver or kidney problems

  • Use caution while driving or operating machinery due to potential dizziness

  • Avoid alcohol, which can enhance side effects like dizziness and hypotension

  • Do not combine with erectile dysfunction medications unless advised by a doctor

Warnings:

  • Not intended for immediate relief of acute angina attacks

  • Pregnant or breastfeeding women should use only if prescribed

  • Overuse or overdose can cause dangerously low blood pressure or fainting

  • Store in a cool, dry place, away from sunlight and children

Adhering to these precautions ensures safe and effective therapy.

Conclusion

CARDULES ISMN SR 30, containing Isosorbide Mononitrate IP 30 mg, is an effective and reliable medication for the prevention and management of angina pectoris and ischemic heart disease. Its sustained-release formulation ensures consistent blood vessel relaxation, reduces cardiac workload, and enhances heart oxygen supply.

With proper use under medical supervision, CARDULES ISMN SR 30 prevents angina attacks, improves exercise tolerance, and enhances quality of life for patients with chronic heart conditions. For individuals seeking a long-term, well-tolerated solution for angina prevention, CARDULES ISMN SR 30 is a clinically proven and dependable choice.


 2025-12-19T09:45:44

Keywords